Diligence memo · auto-generated · as of July 3, 2026
Ala Wai Pharma, Inc.
Ala Wai Pharma, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Ala Wai Pharma, Inc. operates in Pharmaceuticals, based in HONOLULU.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ala Wai Pharma, Inc. has raised $800K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $500K on 2013-07-05.
Most recent recorded round closed around 2013-07-05.
Valuation (modeled)modeled
Provath models Ala Wai Pharma, Inc. at approximately $24M (range $280K–$268M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.08× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 19 months.
Last raise 13.0 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 17% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.